ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-16.75%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$300M
AUM Growth
+$300M
(-12%)
Cap. Flow
-$367K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
40.88%
Holding
110
New
17
Increased
29
Reduced
31
Closed
33
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$9.76M |
| 2 |
AET
Aetna Inc
AET
|
$8.57M |
| 3 |
STJ
St Jude Medical
STJ
|
$5.18M |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$4.72M |
| 5 |
Encompass Health
EHC
|
$4.65M |
Top Sells
| 1 |
BCR
CR Bard Inc.
BCR
|
$9.76M |
| 2 |
Labcorp
LH
|
$9M |
| 3 |
Elevance Health
ELV
|
$6.68M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$6.22M |
| 5 |
Intuitive Surgical
ISRG
|
$4.22M |
Sector Composition
| 1 | Healthcare | 88.86% |
| 2 | Financials | 3.68% |
| 3 | Industrials | 1.11% |
| 4 | Technology | 1.01% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $15.5M | 5.17% | 245,526 +82,112 | +50% | +$5.18M |
|
2
Thermo Fisher Scientific
TMO
$186B
| $14.9M | 4.96% | 121,574 +12,624 | +12% | +$1.54M |
|
3
Becton Dickinson
BDX
$55.3B
| $14.3M | 4.76% | 107,493 -26,367 | -20% | -$3.5M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $13.2M | 4.39% | 233,100 +44,300 | +23% | +$2.5M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $12.4M | 4.14% | 45,566 -12,600 | -22% | -$3.42M |
|
6
Merck
MRK
$210B
| $11.9M | 3.96% | 240,405 +38,100 | +19% | +$1.88M |
|
|
AET
7
DELISTED
Aetna Inc
AET
| $11M | 3.68% | 100,850 +78,300 | +347% | +$8.57M |
|
|
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $10.2M | 3.39% | 159,009 +152,700 | +2,420% | +$9.76M |
|
9
UnitedHealth
UNH
$281B
| $9.84M | 3.28% | 84,800 +4,400 | +5% | +$510K |
|
10
Globus Medical
GMED
$8.27B
| $9.37M | 3.13% | 453,729 -91,110 | -17% | -$1.88M |
|
11
Stryker
SYK
$150B
| $8.5M | 2.84% | 90,286 +38,847 | +76% | +$3.66M |
|
12
HCA Healthcare
HCA
$94.5B
| $8.05M | 2.69% | 104,025 +35,930 | +53% | +$2.78M |
|
13
Universal Health Services
UHS
$11.6B
| $7.17M | 2.39% | 57,475 -21,100 | -27% | -$2.63M |
|
14
Medtronic
MDT
$119B
| $6.98M | 2.33% | 104,318 -21,644 | -17% | -$1.45M |
|
|
SPNC
15
DELISTED
Spectranetics Corp
SPNC
| $6.65M | 2.22% | 563,650 +359,100 | +176% | +$4.23M |
|
|
ESRX
16
DELISTED
Express Scripts Holding Company
ESRX
| $6.17M | 2.06% | 76,187 +29,487 | +63% | +$2.39M |
|
17
Johnson & Johnson
JNJ
$427B
| $5.59M | 1.87% | 59,900 -18,700 | -24% | -$1.75M |
|
|
ALR
18
DELISTED
AlerisLife Inc. Common Stock
ALR
| $4.97M | 1.66% | 1,608,023 +714,671 | +80% | +$2.21M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $4.89M | 1.63% | 105,300 +90,800 | +626% | +$4.21M |
|
|
BXLT
20
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $4.72M | 1.57% | +149,700 | New | +$4.72M |
|
21
Abbott
ABT
$231B
| $4.69M | 1.57% | 116,605 +94,255 | +422% | +$3.79M |
|
|
22
Encompass Health
EHC
$12.3B
| $4.65M | 1.55% | +121,300 | New | +$4.65M |
|
23
Centene
CNC
$14.3B
| $4.41M | 1.47% | +81,364 | New | +$4.41M |
|
24
Viatris
VTRS
$12.3B
| $4.35M | 1.45% | 108,100 +76,000 | +237% | +$3.06M |
|
25
Boston Scientific
BSX
$156B
| $4.18M | 1.4% | 254,700 +109,600 | +76% | +$1.8M |
|